Biopharma R&D Information & Custom Report Preparation

La Merie Publishing is an independent business information provider for the biotechnology and pharmaceutical industry. We publish reports, offer R&D database access, and prepare tailor-made custom reports on a fee-for-service basis. Our products and subscription services are commercialized via our online store www.lamerie.com and via selected Resellers.

Latest Products

October of 2021
Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective
€ 2250.00
July of 2021
Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective
€ 2150.00
March of 2021
2020 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics
€ 100.00
September of 2020
CD47 – SIRPalpha Pathway Inhibitors – Target Pipeline List 09/2020
€ 200.00

Blog

Prodrug antibodies and cytokines generated by masking technologies provide plenty of opportunities for founders, investors and partnerships

October 6, 2021

BARCELONA, Spain I October 06, 2021 I La Merie Publishing announced the release of its newest report about antibody and cytokine prodrugs . The report “Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: an emerging new technology

July 1, 2021

Landscape Analysis of Targeted Protein Degradation by Novel PROTACs and Molecular Glues

May 14, 2020

The growing field of bispecific T-cell and NK cell engaging antibodies offers great opportunities for technology and product development companies

June 11, 2019

FREE Newsletter

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.

Biopharma R&D Information &
Custom Report Preparation

Home

Product of the Month

Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Featured Products

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Antibody Target, Technology & Pipeline Database: 1-Year Subscription